Esterified Estrogens And Methyltestosterone Tablet
Product Images NDC 82619-137

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Esterified Estrogens And Methyltestosterone (NDC 82619-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Creekwood Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (32bf1bc1 6996 4094 86cb B081ef489b06 01)

FDA Label Image

Image (32bf1bc1 6996 4094 86cb B081ef489b06 02)

FDA Label Image

Hs (32bf1bc1 6996 4094 86cb B081ef489b06 03)

Hs (32bf1bc1 6996 4094 86cb B081ef489b06 03)
This text is about a medication labeled NDC 82619-136-01, which is a combination of Esterified Estrogens and Methyltestosterone Tablets at half strength. Each tablet contains 0.625 mg of Esterified Estrogens, USP and 1.25 mg of Methyltestosterone, USP. The dosage information is in the package insert, and patients should receive a patient information leaflet about estrogens. The storage conditions recommend keeping it at 20°-25°C (68°-77°F) with excursions permitted to 15°-30°C (59°-86°F). The product is distributed by Creekwood Pharmaceuticals LLC in Parsippany, NJ.*
FDA Label Image

Fs (32bf1bc1 6996 4094 86cb B081ef489b06 04)

Fs (32bf1bc1 6996 4094 86cb B081ef489b06 04)
This text provides detailed information about tablets with the NDC number 82619-137-01 containing Esterified Estrogens and Methyltestosterone in full strength. Each tablet contains Esterified Estrogens (1.25 mg) and Methyltestosterone (2.5 mg). The instructions recommend storing the tablets at 20°-25°C, with excursions permitted to 15°-30°C. The dosage information should be checked on the package insert for full prescribing guidance. Each package dispensed should include a patient information leaflet about estrogens. The tablets are distributed by Creekwood Pharmaceuticals LLC in Parsippany, NJ. The text also includes a GTIN number and revision date. For more information, a patient package insert can be found at www.creekwoodpharma.com/products/.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.